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There are several causes of adult-onset chorea, with Huntington’s
disease (HD) being the most common. We report a patient who developed
a complex movement disorder consisting of chorea and dystonia asso-
ciated with caudate atrophy on brain magnetic resonance imaging (MRI)
because of a paraneoplastic etiology that can be easily confused with HD.
He was found to have elevated titers of Purkinje cell cytoplasmic antibody
(PCA-2) in the serum and cerebrospinal fluid (CSF).
A 70-year-old Caucasian male with no pertinent past medical
history was referred for complaints of unintentional weight loss,
weakness, and involuntary movements. Over the past year, he had
experienced progressive weakness in his legs such that he required a
walker. As his weakness progressed, he developed bladder and bowel
incontinence, further gait decline, and 60-pound (27-kg) weight loss.
During the course of his weight loss and gait decline, he developed
involuntary movements of the mouth, abnormal posturing of the
hands, and dysarthria. His involuntary movements disappeared during
sleep and while he was eating or drinking. The tongue did not push
food out and he was able to eat and swallow without difficulty. There
was no history of medication intake that could cause these involuntary
(tardive) movements. The family history was negative for neurode-
generative disorders. He had a 30 pack-year smoking history and prior
history of heavy alcohol intake. Clonazepam was prescribed to help
with the involuntary movements, which resulted in mild improvement
as seen in the latter half of the video (Video 1).
His general examination was significant for cachexia. On neurolo-
gical examination, he was alert and oriented. Cranial nerves were
intact with the exception of the involuntary movements discussed
below. Ocular motor examination did not reveal any impairment in
saccades or smooth pursuit. Strength and reflexes in the upper
extremities were normal. Strength testing in the lower extremities
showed bilateral hip flexors (Medical Research Council [MRC] grade
2/5), knee flexors (MRC grade 2/5), knee extensors (MRC grade 3/5),
ankle dorsiflexors (MRC grade 4/5), and plantar flexors (MRC grade
4/5). Reflexes were increased in the lower extremities with clonus and
bilateral extensor plantar responses. Sensory testing was normal.
Coordination was found to be normal on finger–nose–finger testing.
As far as his involuntary movements were concerned, overall they
could be best described as a combination of dystonia and chorea. He
had involuntary, irregular, continuous, and partially suppressible
dystonic movements around the mouth leading to opening of the jaw
and protrusion of the tongue. His left eye closure was suggestive of
unilateral blepharospasm. His hands assumed dystonic posturing while
holding a towel to clear oral secretions. His movements in the neck,
upper limbs, and trunk appear to be choreiform in nature (Video 1).
MRI of the brain showed bilateral caudate atrophy along with
global parenchymal loss (Figure 1). MRI studies of the cervical,
thoracic, and lumbar spine with and without contrast were normal.
Electromyography and nerve conduction studies did not show
evidence of neuropathy or motor neuron disease. A movement neuro-
physiology study showed co-contraction of agonist and antagonist
muscles in the upper extremities suggestive of dystonia. The follow-
ing investigations were negative or normal: human immunodeficiency
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virus 1/2 antibody, Human T-cell lymphotropic virus (HTLV) I/II
antibody, copper, vitamin B12, ceruloplasmin, ferritin, peripheral
smear for acanthocytes, antinuclear antibody, thyroid stimulating
hormone, thyroperoxidase antibody, celiac disease panel, creatine
kinase, aspartate transaminase, alanine transaminase, vitamin E,
antiphospholipid antibody, syphilis antibody immunoglobulin (Ig)G,
and glutamic acid decarboxylase (GAD65) antibody. A polymerase chain
reaction-based assay was utilized to detect cytosine–adenine–guanine
(CAG) repeat expansions in exon 1 of the HTT gene (Huntingtin),
which showed 19/20 CAG repeats. A paraneoplastic antibody panel
performed in both the serum and CSF showed elevated titers of PCA-2
(1:15,360 in the serum and 1:512 in the CSF). Computed tomography
scan of the chest, abdomen, and pelvis demonstrated left mediastinal
adenopathy and a positron emission tomography scan showed
hypermetabolism in the same area that was suspicious for malignancy.
A biopsy of the lymph node was negative for malignancy and the
patient chose to be transferred to a hospice after seven sessions of
plasma exchange failed to show any benefit. Owing to recurrent
infections, treatment with other immunosuppressive agents was not
considered.
PCA-2 was identified by Vernino et al.1 in 10 patients with subacute
neurological syndrome associated with small cell lung cancer (SCLC).
This antibody has been reported to cause ataxia, encephalitis, motor
neuropathy, dysautonomia, and Lambert–Eaton myasthenic syn-
drome.1,2 PCA-2 is specific for the presence of SCLC and it has not
been reported to be associated with any other cancer. The biopsy for
the presence of malignancy can initially be negative, as it was in our
case.1,2 The following antibodies were found in a review of 14 cases of
paraneoplastic chorea: CRMP-5 (collapsin response-mediator protein
5)-Ig, amphiphysin-IgG, GAD65, VGCC-P/Q type (voltage-gated
calcium channel), striational, anti-Hu, and anti-Ri.3 Our case is the
first in the literature to identify PCA-2 leading to a hyperkinetic
movement disorder (chorea–dystonia in our case) associated with
caudate atrophy on brain MRI. A case of chorea with caudate atrophy
associated with SCLC was described in 1997. This patient was later
Video 1. Neurologic Examination Demonstrating a Complex
Movement Disorder. The video shows dysarthria and jaw opening as well as
tongue protrusion dystonia that improves while drinking and is suppressible.
There is dystonic posturing of the hands while using the towel and
blepharospasm on the left side. The chorea is evident in the neck, trunk, and
upper limbs. The latter part of the video shows some improvement of the
above-mentioned movements with clonazepam.
Figure 1. Neuroimaging Study. Magnetic resonance imaging of the brain axial T1 (A) and coronal T1 (B) Axial T1 and coronal T1: bilateral caudate atrophy
with global parenchymal loss.
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found to have anti-Hu antibody and showed transient improvement
with intravenous corticosteroids.4 It is rare for a paraneoplastic
etiology to cause a combination of hyperkinetic movement disorder
and caudate atrophy. Paraneoplastic etiology of chorea tends to be
more common in older male patients with coexisting peripheral
neuropathy or weight loss.3 The two other disorders associated with
chorea and caudate atrophy are chorea–acanthocytosis and McLeod
syndrome.5 These two conditions are usually associated with areflexia
and muscle atrophy.5 The presence of upper motor neuron signs,
paucity of chorea in the lower extremities, lack of psychiatric features,
and normal extraocular movements distinguish our patient’s clinical
picture from classic HD. The treatment of paraneoplastic neurologic
disorders involves treating the underlying cancer and immunotherapy.
If the antibody is directed towards the cell surface antigen (e.g. anti-N-
methyl-D-aspartate receptor encephalitis) then plasma exchange or
intravenous immunoglobulin may result in some improvement by
removing the antibody. However, neurologic dysfunction can also be
mediated by the cytotoxic T-cells when the antigen is intracellular (e.g.
PCA-1, PCA-2, GAD65, etc.) as in our case. The response to
immunotherapy in such cases can be variable and cyclophosphamide
should be considered because it is directed at the cytotoxic T-cell
response.2,6
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